Elder Care

Among heart attack survivors, drug reduces chances of second heart attack or stroke

In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.

Related posts

Rethinking the stroke rule ‘time is brain’


Discovery could explain failed clinical trials for Alzheimer’s, and provide a solution


New findings on bacteria in female bladders